501
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Pediatric use of omalizumab for allergic asthma

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 695-703 | Received 27 Jan 2020, Accepted 31 Mar 2020, Published online: 13 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefano Passanisi, Lucia Caminiti, Giuseppina Zirilli, Fortunato Lombardo, Giuseppe Crisafulli, Tommaso Aversa & Giovanni B Pajno. (2021) Biologics in food allergy: up-to-date. Expert Opinion on Biological Therapy 21:9, pages 1227-1235.
Read now

Articles from other publishers (6)

Colin M. RogersonAlexander H. HoganBriana WaldoBenjamin R. WhiteChristopher L CarrollSteven L. Shein. (2023) Wide Institutional Variability in the Treatment of Pediatric Critical Asthma: A Multicenter Retrospective Study. Pediatric Critical Care Medicine.
Crossref
Riccardo Castagnoli, Ilaria Brambilla, Mattia Giovannini, Gian Luigi Marseglia & Amelia Licari. (2023) New approaches in childhood asthma treatment. Current Opinion in Allergy & Clinical Immunology 23:4, pages 319-326.
Crossref
Elena Camelia Berghea, Mihaela Balgradean, Carmen Pavelescu, Catalin Gabriel Cirstoveanu, Claudia Lucia Toma, Marcela Daniela Ionescu & Roxana Silvia Bumbacea. (2021) Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma—A Romanian Perspective. Children 8:12, pages 1141.
Crossref
Lin Yu, Huishan Zhang, Jianwei Pan & Leping Ye. (2021) Pediatric usage of Omalizumab: A promising one. World Allergy Organization Journal 14:12, pages 100614.
Crossref
Riccardo Castagnoli, Maria De Filippo, Martina Votto, Alessia Marseglia, Lorenza Montagna, Gian Luigi Marseglia & Amelia Licari. (2020) An update on biological therapies for pediatric allergic diseases. Minerva Pediatrica 72:5.
Crossref
Martin Klein, Luc Colas, Marie-Aude Cheminant, Carole Brosseau, Vincent Sauzeau, Antoine Magnan & Grégory Bouchaud. (2020) Der p 2.1 Peptide Abrogates House Dust Mites-Induced Asthma Features in Mice and Humanized Mice by Inhibiting DC-Mediated T Cell Polarization. Frontiers in Immunology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.